255 related articles for article (PubMed ID: 18420933)
1. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors.
Witze ES; Litman ES; Argast GM; Moon RT; Ahn NG
Science; 2008 Apr; 320(5874):365-9. PubMed ID: 18420933
[TBL] [Abstract][Full Text] [Related]
2. Cell signaling. Wnt moves beyond the canon.
Bowerman B
Science; 2008 Apr; 320(5874):327-8. PubMed ID: 18420922
[TBL] [Abstract][Full Text] [Related]
3. Wnt5a directs polarized calcium gradients by recruiting cortical endoplasmic reticulum to the cell trailing edge.
Witze ES; Connacher MK; Houel S; Schwartz MP; Morphew MK; Reid L; Sacks DB; Anseth KS; Ahn NG
Dev Cell; 2013 Sep; 26(6):645-57. PubMed ID: 24091015
[TBL] [Abstract][Full Text] [Related]
4. Rear-polarized Wnt5a-receptor-actin-myosin-polarity (WRAMP) structures promote the speed and persistence of directional cell migration.
Connacher MK; Tay JW; Ahn NG
Mol Biol Cell; 2017 Jul; 28(14):1924-1936. PubMed ID: 28592632
[TBL] [Abstract][Full Text] [Related]
5. Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes.
Babayeva S; Zilber Y; Torban E
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F549-60. PubMed ID: 20534871
[TBL] [Abstract][Full Text] [Related]
6. Protein Depalmitoylation Is Induced by Wnt5a and Promotes Polarized Cell Behavior.
Wang W; Runkle KB; Terkowski SM; Ekaireb RI; Witze ES
J Biol Chem; 2015 Jun; 290(25):15707-15716. PubMed ID: 25944911
[TBL] [Abstract][Full Text] [Related]
7. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
[TBL] [Abstract][Full Text] [Related]
8. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
[TBL] [Abstract][Full Text] [Related]
9. Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension.
Ye Z; Zhang C; Tu T; Sun M; Liu D; Lu D; Feng J; Yang D; Liu F; Yan X
Nat Commun; 2013; 4():2803. PubMed ID: 24335906
[TBL] [Abstract][Full Text] [Related]
10. Wnt5A activates the calpain-mediated cleavage of filamin A.
O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
[TBL] [Abstract][Full Text] [Related]
11. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.
Camilli TC; Xu M; O'Connell MP; Chien B; Frank BP; Subaran S; Indig FE; Morin PJ; Hewitt SM; Weeraratna AT
Pigment Cell Melanoma Res; 2011 Feb; 24(1):175-86. PubMed ID: 20955350
[TBL] [Abstract][Full Text] [Related]
12. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
[TBL] [Abstract][Full Text] [Related]
13. Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively.
Shojima K; Sato A; Hanaki H; Tsujimoto I; Nakamura M; Hattori K; Sato Y; Dohi K; Hirata M; Yamamoto H; Kikuchi A
Sci Rep; 2015 Jan; 5():8042. PubMed ID: 25622531
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
[TBL] [Abstract][Full Text] [Related]
15. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
16. Regulation of focal adhesion dynamics by Wnt5a signaling.
Matsumoto S; Kikuchi A
Methods Mol Biol; 2012; 839():215-27. PubMed ID: 22218904
[TBL] [Abstract][Full Text] [Related]
17. RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane.
Sandilands E; Cans C; Fincham VJ; Brunton VG; Mellor H; Prendergast GC; Norman JC; Superti-Furga G; Frame MC
Dev Cell; 2004 Dec; 7(6):855-69. PubMed ID: 15572128
[TBL] [Abstract][Full Text] [Related]
18. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
[TBL] [Abstract][Full Text] [Related]
19. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
Ekström EJ; Sherwood V; Andersson T
PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614
[TBL] [Abstract][Full Text] [Related]
20. Wnt/planar cell polarity signaling controls the anterior-posterior organization of monoaminergic axons in the brainstem.
Fenstermaker AG; Prasad AA; Bechara A; Adolfs Y; Tissir F; Goffinet A; Zou Y; Pasterkamp RJ
J Neurosci; 2010 Nov; 30(47):16053-64. PubMed ID: 21106844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]